142 related articles for article (PubMed ID: 12177783)
1. Molecular classification of selective oestrogen receptor modulators on the basis of gene expression profiles of breast cancer cells expressing oestrogen receptor alpha.
Levenson AS; Kliakhandler IL; Svoboda KM; Pease KM; Kaiser SA; Ward JE; Jordan VC
Br J Cancer; 2002 Aug; 87(4):449-56. PubMed ID: 12177783
[TBL] [Abstract][Full Text] [Related]
2. Gene expression profiles with activation of the estrogen receptor alpha-selective estrogen receptor modulator complex in breast cancer cells expressing wild-type estrogen receptor.
Levenson AS; Svoboda KM; Pease KM; Kaiser SA; Chen B; Simons LA; Jovanovic BD; Dyck PA; Jordan VC
Cancer Res; 2002 Aug; 62(15):4419-26. PubMed ID: 12154049
[TBL] [Abstract][Full Text] [Related]
3. Xenoestrogens and the induction of proliferative effects in breast cancer cells via direct activation of oestrogen receptor alpha.
Recchia AG; Vivacqua A; Gabriele S; Carpino A; Fasanella G; Rago V; Bonofiglio D; Maggiolini M
Food Addit Contam; 2004 Feb; 21(2):134-44. PubMed ID: 14754635
[TBL] [Abstract][Full Text] [Related]
4. Oestrogenic activity of isobutylparaben in vitro and in vivo.
Darbre PD; Byford JR; Shaw LE; Horton RA; Pope GS; Sauer MJ
J Appl Toxicol; 2002; 22(4):219-26. PubMed ID: 12210538
[TBL] [Abstract][Full Text] [Related]
5. Genome-wide identification of direct target genes implicates estrogen-related receptor alpha as a determinant of breast cancer heterogeneity.
Deblois G; Hall JA; Perry MC; Laganière J; Ghahremani M; Park M; Hallett M; Giguère V
Cancer Res; 2009 Aug; 69(15):6149-57. PubMed ID: 19622763
[TBL] [Abstract][Full Text] [Related]
6. Oestrogen receptors pathways to oestrogen responsive elements: the transactivation function-1 acts as the keystone of oestrogen receptor (ER)beta-mediated transcriptional repression of ERalpha.
Gougelet A; Mueller SO; Korach KS; Renoir JM
J Steroid Biochem Mol Biol; 2007 May; 104(3-5):110-22. PubMed ID: 17478088
[TBL] [Abstract][Full Text] [Related]
7. Comparative study of oestrogenic properties of eight phytoestrogens in MCF7 human breast cancer cells.
Matsumura A; Ghosh A; Pope GS; Darbre PD
J Steroid Biochem Mol Biol; 2005 Apr; 94(5):431-43. PubMed ID: 15876408
[TBL] [Abstract][Full Text] [Related]
8. Molecular identification of ERalpha-positive breast cancer cells by the expression profile of an intrinsic set of estrogen regulated genes.
Weisz A; Basile W; Scafoglio C; Altucci L; Bresciani F; Facchiano A; Sismondi P; Cicatiello L; De Bortoli M
J Cell Physiol; 2004 Sep; 200(3):440-50. PubMed ID: 15254972
[TBL] [Abstract][Full Text] [Related]
9. First evidence supporting a potential role for the BMP/SMAD pathway in the progression of oestrogen receptor-positive breast cancer.
Helms MW; Packeisen J; August C; Schittek B; Boecker W; Brandt BH; Buerger H
J Pathol; 2005 Jul; 206(3):366-76. PubMed ID: 15892165
[TBL] [Abstract][Full Text] [Related]
10. Molecular signatures of estrogen receptor-associated genes in breast cancer predict clinical outcome.
Wittliff JL; Kruer TL; Andres SA; Smolenkova I
Adv Exp Med Biol; 2008; 617():349-57. PubMed ID: 18497058
[TBL] [Abstract][Full Text] [Related]
11. Resveratrol acts as an estrogen receptor (ER) agonist in breast cancer cells stably transfected with ER alpha.
Levenson AS; Gehm BD; Pearce ST; Horiguchi J; Simons LA; Ward JE; Jameson JL; Jordan VC
Int J Cancer; 2003 May; 104(5):587-96. PubMed ID: 12594813
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of transcriptional activity of the oestrogen receptor with sodium iodide symporter as an imaging reporter gene.
Kang JH; Chung JK; Lee YJ; Kim KI; Jeong JM; Lee DS; Lee MC
Nucl Med Commun; 2006 Oct; 27(10):773-7. PubMed ID: 16969258
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer oestrogen independence mediated by BCAR1 or BCAR3 genes is transmitted through mechanisms distinct from the oestrogen receptor signalling pathway or the epidermal growth factor receptor signalling pathway.
Dorssers LC; van Agthoven T; Brinkman A; Veldscholte J; Smid M; Dechering KJ
Breast Cancer Res; 2005; 7(1):R82-92. PubMed ID: 15642172
[TBL] [Abstract][Full Text] [Related]
14. Silencing and reactivation of the selective estrogen receptor modulator-estrogen receptor alpha complex.
Liu H; Lee ES; Deb Los Reyes A; Zapf JW; Jordan VC
Cancer Res; 2001 May; 61(9):3632-9. PubMed ID: 11325832
[TBL] [Abstract][Full Text] [Related]
15. Gene expression profiles of breast cancer obtained from core cut biopsies before neoadjuvant docetaxel, adriamycin, and cyclophoshamide chemotherapy correlate with routine prognostic markers and could be used to identify predictive signatures.
Rody A; Karn T; Gätje R; Kourtis K; Minckwitz G; Loibl S; Munnes M; Ruckhäberle E; Holtrich U; Kaufmann M; Ahr A
Zentralbl Gynakol; 2006 Apr; 128(2):76-81. PubMed ID: 16673249
[TBL] [Abstract][Full Text] [Related]
16. A modular analysis of breast cancer reveals a novel low-grade molecular signature in estrogen receptor-positive tumors.
Yu K; Ganesan K; Miller LD; Tan P
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3288-96. PubMed ID: 16740749
[TBL] [Abstract][Full Text] [Related]
17. Estrogen receptor isoform-specific regulation of endogenous gene expression in human osteoblastic cell lines expressing either ERalpha or ERbeta.
Monroe DG; Getz BJ; Johnsen SA; Riggs BL; Khosla S; Spelsberg TC
J Cell Biochem; 2003 Oct; 90(2):315-26. PubMed ID: 14505348
[TBL] [Abstract][Full Text] [Related]
18. An oestrogen-dependent model of breast cancer created by transformation of normal human mammary epithelial cells.
Duss S; André S; Nicoulaz AL; Fiche M; Bonnefoi H; Brisken C; Iggo RD
Breast Cancer Res; 2007; 9(3):R38. PubMed ID: 17573968
[TBL] [Abstract][Full Text] [Related]
19. Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns.
Gruvberger S; Ringnér M; Chen Y; Panavally S; Saal LH; Borg A ; Fernö M; Peterson C; Meltzer PS
Cancer Res; 2001 Aug; 61(16):5979-84. PubMed ID: 11507038
[TBL] [Abstract][Full Text] [Related]
20. Domains of estrogen receptor alpha (ERalpha) required for ERalpha/Sp1-mediated activation of GC-rich promoters by estrogens and antiestrogens in breast cancer cells.
Kim K; Thu N; Saville B; Safe S
Mol Endocrinol; 2003 May; 17(5):804-17. PubMed ID: 12576490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
